John R. Stuelpnagel - 30 Dec 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
30 Dec 2021
Net transactions value
-$754,590
Form type
4
Filing time
04 Jan 2022, 17:13:45 UTC
Previous filing
03 Dec 2021
Next filing
17 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $484,501 -3,218 -0.93% $150.56 343,398 30 Dec 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $270,089 -1,782 -0.52% $151.56 341,616 30 Dec 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $151.02 to $151.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.